Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Aug 11, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
- Aug 11, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Jul 10, 2026Reported sale · Form 4Sukumar Nagendran, President and Head of R&D · $1.2MOpen the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record37422 flagged findings
Reported transactions (Form 4)80since Feb 2, 2023 · and 2 other holdings
Corporate events (8-K)29since Nov 4, 2020
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-05-06share offering or dilution eventrecentOpen filing ↗“…the holder of the SSI Warrants will not have the right to exercise any portion of its SSI Warrants until the achievement of…”
+1 more passage from the same document
- “…2023, the Company entered into a Securities Purchase Agreement (the “August 2023 Purchase Agreement”) with certain institutional…”
- 2026-05-06capital return (buybacks/dividends)recentOpen filing ↗“…as a component of stockholders’ equity within additional paid-in capital. The May 2025 Pre-funded Warrants are equity classified…”
+1 more passage from the same document
- “…as a component of stockholders’ equity within additional paid-in capital. The June 2024 Pre-funded Warrants are equity classified…”
- 2026-03-19share offering or dilution eventrecentOpen filing ↗“…2023, the Company entered into a Securities Purchase Agreement (the “August 2023 Purchase Agreement”) with certain institutional…”
+1 more passage from the same document
- “…ownership limitation; provided, however, that a holder may increase or decrease the beneficial ownership limitation by giving 61…”
- 2026-03-19capital return (buybacks/dividends)recentOpen filing ↗“…as a component of stockholders’ equity within additional paid-in capital. The May 2025 Pre-funded Warrants are equity classified…”
+1 more passage from the same document
- “…as a component of stockholders’ equity within additional paid-in capital. The June 2024 Pre-funded Warrants are equity classified…”
- 2026-03-19regulatory investigationrecentOpen filing ↗“…thereto) submitted by us or our strategic partners; • restrict the marketing or manufacturing of the drug; • seize or detain the…”
- 2026-03-19Department of Justice inquiryrecentOpen filing ↗“…particularly to the United States, are subject to increased scrutiny from regulators, individual litigants, and activist…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 374)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Aug 14, 26SCHEDULE 13G/A ↗Passive stake · RA Capital Management, L.P. · 9.9% · event on Jun 30, 26 · amendment
- Aug 13, 26SCHEDULE 13G/A ↗Passive stake · Morgan Stanley · 5.1% · event on Jun 30, 26 · amendment
- Aug 11, 2610-Q ↗Quarterly report
- Aug 11, 268-K ↗Current report · Results
- Jul 10, 26Form 144 ↗Notice of proposed sale
- Jul 10, 26Form 4 ↗Insider transaction
- Jun 25, 268-K ↗Current report · Entered a material agreement
- Jun 25, 26424B5 ↗Securities offering
- Jun 24, 26424B5 ↗Securities offering
- Jun 22, 268-K ↗Current report · Communication to the market · Other events
- Jun 2, 268-K ↗Current report · Shareholder vote results
- May 15, 26SCHEDULE 13G/A ↗Passive stake · RTW Investments, LP · 7.0% · event on Mar 31, 26 · amendment
- May 15, 26SCHEDULE 13G/A ↗Passive stake · Vestal Point Capital, LP · 6.3% · event on Mar 31, 26 · amendment
- May 6, 2610-Q ↗Quarterly report
- May 6, 268-K ↗Current report · Results
- Apr 22, 26DEFA14A ↗Shareholder meeting and votes
- Apr 22, 26DEF 14A ↗Shareholder meeting and votes
- Apr 13, 26Form 4 ↗Insider transaction
- Apr 10, 26Form 144 ↗Notice of proposed sale
- Mar 19, 2610-K ↗Annual report
- Mar 19, 268-K ↗Current report · Results
374 filings on record, the oldest from Sep 2, 20.
Listing the 25 most recent filings of the 374 on record.
21710
4 material agreements entered2024 – 2026show all 4hide
- Jun 25, 26Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Nov 4, 25Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- May 29, 25Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Jun 26, 24Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Dec 20, 23A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Nov 1, 23A senior executive left or was appointed8-K 5.02 ↗
- Aug 14, 23Entered a material agreement+4 more in the same filing8-K 1.01 ↗
- Aug 4, 23Listing notice (8-K 3.01)8-K 3.01 ↗
- Jun 22, 23A senior executive left or was appointed8-K 5.02 ↗
- Jun 6, 23A senior executive left or was appointed8-K 5.02 ↗
- Apr 27, 23Listing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
4 senior executive changes2022 – 2023show all 4hide
- Mar 8, 23A senior executive left or was appointed8-K/A 5.02 ↗
- Jan 19, 23A senior executive left or was appointed8-K 5.02 ↗
- Jan 6, 23A senior executive left or was appointed8-K/A 5.02 ↗
- Dec 22, 22A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
5 material agreements entered2020 – 2022show all 5hide
- Oct 31, 22Entered a material agreement+3 more in the same filing8-K/A 1.01 ↗
- Oct 27, 22Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Oct 25, 22Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Jan 15, 21Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Dec 17, 20Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Nov 24, 20A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Nov 12, 20Completed an acquisition or disposal+1 more in the same filing8-K 2.01 ↗
1 older filings not shown
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- Paul B Manning9.8%May 30, 25SCHEDULE 13D/A ↗6 co-filers on this document — the figure is the largest single stake, not their sum.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- RA Capital Management, L.P.9.9%Jun 30, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
- RTW Investments, LP7.0%Mar 31, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
- BlackRock, Inc.6.5%Dec 31, 25SCHEDULE 13G/A ↗1 earlier filing
- Vestal Point Capital, LP6.3%Mar 31, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- Morgan Stanley5.1%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
show 2 more holdershide
- FMR LLC4.9%Dec 31, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- Octagon Capital Advisors LP3.3%Sep 30, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Sale intention announced
On Jul 10, Nagendran Sukumar filed notice of intent to sell up to $1.3M. That is about 0.06% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
After the notice, they sold $1.2M on Jul 10, per their Form 4. That is 100% of the shares announced.
- Jul 10, 26Sell$1.2MSukumar NagendranPresident and Head of R&D↗
- Apr 10, 26Sell$892KSukumar NagendranPresident and Head of R&D↗
- Feb 4, 26Sell$7KKamran AlamCHIEF FINANCIAL OFFICER↗
- Jan 26, 26Sell$190KSean P. NolanChief Executive Officer↗
- Jan 26, 26Sell$124KSukumar NagendranPresident and Head of R&D↗
- Jan 26, 26Sell$110KKamran AlamCHIEF FINANCIAL OFFICER↗
- Jan 23, 26Sell$650KSean P. NolanChief Executive Officer↗
- Jan 23, 26Sell$423KSukumar NagendranPresident and Head of R&D↗
- Jan 23, 26Sell$375KKamran AlamCHIEF FINANCIAL OFFICER↗
- Jan 12, 26Sell$942KSukumar NagendranPresident and Head of R&D↗
- Dec 1, 25Sell$1.2MSukumar NagendranPresident and Head of R&D↗
- Nov 28, 25Sell$523KSukumar NagendranPresident and Head of R&D↗
There are 5 more transactions in this stretch.
Stock compensation, tax and giftsshow the 23 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Jun 1, 26Compensationamount n/aPhillip B. Donenberg↗
- Jun 1, 26Compensationamount n/aJohn A Stalfort III↗
- Jun 1, 26Compensationamount n/aLaura Sepp-Lorenzino↗
- Jun 1, 26Compensationamount n/aAlison S Long↗
- Apr 10, 26Compensation$33KSukumar NagendranPresident and Head of R&D↗
- Jan 12, 26Compensationamount n/aSean P. NolanChief Executive Officer↗
- Jan 12, 26Compensation$78KSukumar NagendranPresident and Head of R&D↗
- Jan 12, 26Compensation$152KSukumar NagendranPresident and Head of R&D↗
- Jan 12, 26Compensationamount n/aSukumar NagendranPresident and Head of R&D↗
- Jan 12, 26Compensationamount n/aKamran AlamCHIEF FINANCIAL OFFICER↗
- Dec 1, 25Compensation$445KSukumar NagendranPresident and Head of R&D↗
- Nov 28, 25Compensation$49KSukumar NagendranPresident and Head of R&D↗
- Nov 28, 25Compensation$68KSukumar NagendranPresident and Head of R&D↗
- Sep 10, 25Compensation$29KSukumar NagendranPresident and Head of R&D↗
- Jun 2, 25Compensationamount n/aLaura Sepp-Lorenzino↗
- Jun 2, 25Compensationamount n/aAlison S Long↗
- Jun 2, 25Compensationamount n/aPhillip B. Donenberg↗
- Jun 2, 25Compensationamount n/aJohn A Stalfort III↗
- Mar 11, 25Tax$50KKamran AlamCHIEF FINANCIAL OFFICER↗
- Jan 2, 25Compensationamount n/aKamran AlamCHIEF FINANCIAL OFFICER↗
- Jan 2, 25Compensationamount n/aSukumar NagendranPresident and Head of R&D↗
- Jan 2, 25Compensationamount n/aSean P. NolanChief Executive Officer↗
- May 29, 24Compensationamount n/aLaura Sepp-Lorenzino↗
The full record holds 65 transactions and goes back to Dec 30, 22.
Its sector and its market
Taysha Gene Therapies Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Taysha Gene Therapies Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Taysha Gene Therapies Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 374 documents on file, from Sep 2, 2020 to Aug 14, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.